Mithra Pharmaceuticals SA (MITRA.BR) Stock Income Statement
EBR:MITRA - Euronext Brussels - BE0974283153 - Common Stock - Currency: EUR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 40.16M | 67.00M | 22.67M | 9.03M | 96.52M | |||
| Cost Of Goods | 21.95M | 19.62M | 15.72M | 3.46M | 2.49M | |||
| Gross Profit | 18.20M | 47.37M | 6.94M | 5.57M | 94.03M | |||
| Operating Expenses | 83.19M | 73.62M | 94.82M | 89.25M | 67.06M | |||
| Research and Development | 63.17M | 64.04M | 85.24M | 78.46M | 57.07M | |||
| Selling, General, and Administrative Expenses | 24.36M | 16.77M | 14.39M | 17.37M | 16.31M | |||
| Operating Income | -64.98M | -26.25M | -87.88M | -83.68M | 26.98M | |||
| Interest Income/Expense | -21.15M | -17.22M | -18.09M | -7.89M | -564.00K | |||
| Other Income/Expense | -1.51M | 31.99M | -17.80M | -19.36M | -57.84M | |||
| Non Recurring Items | -74.15M | N/A | N/A | N/A | -5.07M | |||
| Income Before Taxes | -161.79M | -11.48M | -123.77M | -110.92M | -31.42M | |||
| Income Tax | 11.71M | 48.14M | -6.89M | -18.84M | -4.86M | |||
| Net Income | -173.50M | -59.62M | -116.88M | -92.09M | -26.56M | |||
| EBITDA | N/A | -14.30M | -77.45M | -73.91M | 32.75M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.51 | -1.22 | -2.69 | -2.25 | -0.70 | |||
| Statistics | ||||||||
| Gross Profit Margin | 45.34% | 70.71% | 30.63% | 61.72% | 97.42% | |||
| Profit Margin | -432.08% | -88.99% | -515.59% | -1019.78% | -27.52% | |||
| Operating Profit Margin | -161.84% | -39.17% | -387.66% | -926.67% | 27.95% | |||
All data in EUR